Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Valvular Heart Disease

Free Subscription Articles published in Heart Retrieve available abstracts of 147 articles: HTML format

Single Articles

December 2025
1. ZHOU Z, Zheng Y, Hu S, Xu J, et al
   Multisystem comorbidities and shared genetic pathways in calcific aortic stenosis: a phenome-wide and Mendelian randomisation analysis.
   Heart. 2025 Dec 29:heartjnl-2025-326058. doi: 10.1136/heartjnl-2025-326058.
   PubMed     Abstract available
   
   
   
2. DAVIDSEN AH, Andersen S, Halvorsen PA, Aviles Solis JC, et al
   Heart murmurs in the general population: diagnostic value and prevalence from the Tromso Study.
   Heart. 2025;112:103-110.
   PubMed     Abstract available
   
   
   
3. CHEN M, Sahiti F, Cejka V, Schmidbauer L, et al
   Frequency and natural course of American College of Cardiology/American Heart Association valvular heart disease stages in the general population: results from the population-based STAAB cohort study.
   Heart. 2025 Dec 9:heartjnl-2025-326443. doi: 10.1136/heartjnl-2025-326443.
   PubMed     Abstract available
   
   
   November 2025
4. CHEN M, Yue Z, Xu L, Fan P, et al
   Prosthetic annulus size mismatch and recurrent mitral regurgitation after repair in advanced degenerative disease.
   Heart. 2025 Nov 30:heartjnl-2025-325968. doi: 10.1136/heartjnl-2025-325968.
   PubMed     Abstract available
   
   
   
5. MALAHFJI M
   Natural history of aortic regurgitation in the contemporary era: not so benign.
   Heart. 2025 Nov 24:heartjnl-2025-327335. doi: 10.1136/heartjnl-2025-327335.
   PubMed    
   
   
   
6. NASER JA, Massad F, Al-Abcha A, Gerberi D, et al
   Natural history of asymptomatic moderate or severe aortic regurgitation: a systematic review and meta-analysis.
   Heart. 2025 Nov 17:heartjnl-2025-326643. doi: 10.1136/heartjnl-2025-326643.
   PubMed     Abstract available
   
   
   
7. SALIHU A, Antiochos P, Lu H, Maurizi N, et al
   Association between programmed electrical stimulation inducibility and arrhythmic risk in hypertrophic cardiomyopathy: a systematic review and meta-analysis.
   Heart. 2025;111:1135-1140.
   PubMed     Abstract available
   
   
   
8. ABDALWAHAB A, Das R, Alkhalil M
   Inferior ST-segment elevation during transcatheter aortic valve implantation.
   Heart. 2025;111:1167-1168.
   PubMed    
   
   
   October 2025
9. VAN WIJNGAARDEN AL, de Riva M, Sabbag A, El-Am E, et al
   Ventricular arrhythmias during exercise in patients with mitral valve prolapse.
   Heart. 2025 Oct 20:heartjnl-2025-326395. doi: 10.1136/heartjnl-2025-326395.
   PubMed     Abstract available
   
   
   
10. LOVE CJ, Lampert J, Huneycutt D, Musat DL, et al
    Clinical implementation of an AI-enabled ECG for hypertrophic cardiomyopathy detection.
    Heart. 2025;111:1029-1035.
    PubMed     Abstract available
    
    
    September 2025
11. WANG H, Li J, Hsi DH, Li W, et al
    Percutaneous intramyocardial septal radiofrequency ablation: a novel treatment for drug-refractory non-obstructive hypertrophic cardiomyopathy with severe septal hypertrophy.
    Heart. 2025;111:933-940.
    PubMed     Abstract available
    
    
    
12. NISHIURA N, Kubo S, Ono S, Mushiake K, et al
    Prognostic value of leaflet coaptation gap in transcatheter edge-to-edge repair for functional mitral regurgitation.
    Heart. 2025 Sep 8:heartjnl-2024-325585. doi: 10.1136/heartjnl-2024-325585.
    PubMed     Abstract available
    
    
    
13. JIA S, Liu P, Wang M, Zhong X, et al
    Midterm outcomes of rheumatic mitral valve repair versus replacement in a dual-centre retrospective study.
    Heart. 2025 Sep 5:heartjnl-2025-326323. doi: 10.1136/heartjnl-2025-326323.
    PubMed     Abstract available
    
    
    August 2025
14. KUBO T, Sugiura K, Tokita Y, Takano H, et al
    Contemporary clinical characteristics and management patterns in hypertrophic cardiomyopathy: insights from baseline enrolment data in a nationwide prospective Japanese registry.
    Heart. 2025;111:885-892.
    PubMed     Abstract available
    
    
    
15. WANG Z, Qian X, Lv J, Li Z, et al
    Asthma and risk of degenerative valvular heart disease: a prospective cohort study.
    Heart. 2025 Aug 19:heartjnl-2024-325575. doi: 10.1136/heartjnl-2024-325575.
    PubMed     Abstract available
    
    
    
16. CAO D, Sandri M, Garot P, Pelliccia F, et al
    Prevalence and prognostic implications of the Valve Academic Research Consortium-High Bleeding Risk criteria in patients undergoing transcatheter aortic valve implantation.
    Heart. 2025 Aug 12:heartjnl-2025-326043. doi: 10.1136/heartjnl-2025-326043.
    PubMed     Abstract available
    
    
    
17. TSURUMI H, Kusunose K
    Atrial fibrillation in chronic aortic regurgitation: the missing link in prognosis and surgical timing.
    Heart. 2025 Aug 11:heartjnl-2025-326727. doi: 10.1136/heartjnl-2025-326727.
    PubMed    
    
    
    
18. BARBOSA GS, Katsuyama ES, Fukunaga CK, Fernandes JM, et al
    Surgical ablation in non-mitral valve cardiac surgeries: a meta-analysis of early outcomes.
    Heart. 2025 Aug 7:heartjnl-2025-326299. doi: 10.1136/heartjnl-2025-326299.
    PubMed     Abstract available
    
    
    
19. XIANG H, Zhang Y, Zhang Y, Ye Z, et al
    Plasma metabolomics uncovers key metabolites and enhances prediction of aortic stenosis: insights from prospective cohort and Mendelian randomisation studies.
    Heart. 2025 Aug 4:heartjnl-2025-326161. doi: 10.1136/heartjnl-2025-326161.
    PubMed     Abstract available
    
    
    July 2025
20. BHARUCHA AH, Brown S, Theofilatos K, Singh B, et al
    Parsimonious machine learning model to predict 1-year mortality and procedural futility after transcatheter aortic valve replacement.
    Heart. 2025 Jul 25:heartjnl-2025-325928. doi: 10.1136/heartjnl-2025-325928.
    PubMed     Abstract available
    
    
    
21. MATTIG I, Romero Dorta E, Frumkin D, Kretzschmar H, et al
    Sex differences in the prevalence and prognosis of tricuspid regurgitation among patients with heart failure.
    Heart. 2025 Jul 24:heartjnl-2025-325913. doi: 10.1136/heartjnl-2025-325913.
    PubMed     Abstract available
    
    
    
22. CHANG CJ, Chi NH, Wu CH, Huang LY, et al
    Comparative evaluation of biological and mechanical prostheses for aortic valve replacement in a middle-aged population: a population-based cohort study.
    Heart. 2025 Jul 16:heartjnl-2024-325648. doi: 10.1136/heartjnl-2024-325648.
    PubMed     Abstract available
    
    
    
23. PUGLIESI GM, Scott CG, Nkomo VT, Michelena HI, et al
    Prevalence and prognostic role of atrial fibrillation in chronic severe aortic regurgitation.
    Heart. 2025 Jul 16:heartjnl-2025-325823. doi: 10.1136/heartjnl-2025-325823.
    PubMed     Abstract available
    
    
    
24. WILLIXHOFER R, Mapelli M, Baracchini N, Campana N, et al
    Integrating pulmonary function testing with cardiopulmonary exercise testing for enhanced stratification in hypertrophic cardiomyopathy.
    Heart. 2025;111:700-705.
    PubMed     Abstract available
    
    
    
25. TOMSIC A, Velders BJJ, Kawczynski MJ, Schoones JW, et al
    Representativeness of surgical controls in aortic valve replacement trials: comparison with routine surgical cohorts.
    Heart. 2025 Jul 8:heartjnl-2025-326162. doi: 10.1136/heartjnl-2025-326162.
    PubMed     Abstract available
    
    
    June 2025
26. LIM HJ, Kim K, Gwak SY, Lee HJ, et al
    Early predictors of aortic valve surgery in patients with significant bicuspid aortic regurgitation without initial surgical indication.
    Heart. 2025 Jun 20:heartjnl-2025-325892. doi: 10.1136/heartjnl-2025-325892.
    PubMed     Abstract available
    
    
    
27. FALK V
    60: 'the magic number of greatness' in minimally invasive mitral valve repair?
    Heart. 2025 Jun 20:heartjnl-2025-326326. doi: 10.1136/heartjnl-2025-326326.
    PubMed    
    
    
    
28. KASSAR M, Gercek M, Rudolph V
    Shadows and light in transcatheter mitral valve treatment: recent evidence and implications for clinical practice.
    Heart. 2025 Jun 15:heartjnl-2024-325621. doi: 10.1136/heartjnl-2024-325621.
    PubMed    
    
    
    
29. HEUTS S, Kawczynski MJ, Maesen B, Vriesendorp PA, et al
    When absence of evidence equates to evidence of absence: the case of routine use of cerebral embolic protection devices in transcatheter aortic valve implantation.
    Heart. 2025 Jun 10:heartjnl-2025-326208. doi: 10.1136/heartjnl-2025-326208.
    PubMed     Abstract available
    
    
    May 2025
30. SUN Y, Wang C, Li J, Luo S, et al
    Outcomes of transcatheter aortic valve replacement in bicuspid versus tricuspid aortic stenosis with severe calcification.
    Heart. 2025 May 10:heartjnl-2024-324697. doi: 10.1136/heartjnl-2024-324697.
    PubMed     Abstract available
    
    
    
31. NAKASE M, Draxler DF, Tomii D, Heg D, et al
    Incidence, predictors and clinical impact of upper gastrointestinal bleeding after transcatheter aortic valve replacement.
    Heart. 2025 May 10:heartjnl-2024-325359. doi: 10.1136/heartjnl-2024-325359.
    PubMed     Abstract available
    
    
    
32. HEUTS S, Hjij W, Kawczynski MJ, Olsthoorn JR, et al
    Defining centres of expertise for minimally invasive mitral valve surgery: a systematic review and volume-outcome meta-analysis.
    Heart. 2025 May 10:heartjnl-2024-325048. doi: 10.1136/heartjnl-2024-325048.
    PubMed     Abstract available
    
    
    April 2025
33. WANG C, Hamid N, Bapat V, Cavalcante JL, et al
    Incidence, predictors and outcomes of tricuspid regurgitation progression after left-sided valvular intervention.
    Heart. 2025 Apr 30:heartjnl-2024-325194. doi: 10.1136/heartjnl-2024-325194.
    PubMed     Abstract available
    
    
    
34. MCCANN GP, Newby DE, Hillis GS
    TAVI for asymptomatic aortic stenosis? More compelling outcome data are needed.
    Heart. 2025 Apr 15:heartjnl-2025-325767. doi: 10.1136/heartjnl-2025-325767.
    PubMed    
    
    
    
35. JEONG JH, Kim H, Hwang SH, Seo CO, et al
    Genotype and arrhythmic risk in patients with apical hypertrophic cardiomyopathy.
    Heart. 2025 Apr 7:heartjnl-2024-325218. doi: 10.1136/heartjnl-2024-325218.
    PubMed     Abstract available
    
    
    March 2025
36. CELMETA B, Miceli A
    Bacteraemia and infective endocarditis after transcatheter aortic valve replacement: prevention is the key.
    Heart. 2025 Mar 23:heartjnl-2024-325410. doi: 10.1136/heartjnl-2024-325410.
    PubMed    
    
    
    
37. GEERS J, Manral N, Razipour A, Park C, et al
    Epicardial adipose tissue, myocardial remodelling and adverse outcomes in asymptomatic aortic stenosis: a post hoc analysis of a randomised controlled trial.
    Heart. 2025 Mar 6:heartjnl-2024-324925. doi: 10.1136/heartjnl-2024-324925.
    PubMed     Abstract available
    
    
    
38. PANG L, Xia Y, Tang M, Ma M, et al
    Prevalence, spectrum and aetiology of valvular heart disease based on community echocardiographic screening transition from different altitudes in Yunnan, China.
    Heart. 2025 Mar 3:heartjnl-2024-325221. doi: 10.1136/heartjnl-2024-325221.
    PubMed     Abstract available
    
    
    February 2025
39. LEE HJ, Gwak SY, Kim K, Cho I, et al
    Factors associated with high-intensity physical activity and sudden cardiac death in hypertrophic cardiomyopathy.
    Heart. 2025;111:253-261.
    PubMed     Abstract available
    
    
    
40. LIND V, Lundman P, Friberg L, Talback M, et al
    Dysglycaemia and incident aortic stenosis: a cohort study.
    Heart. 2025 Feb 6:heartjnl-2024-325150. doi: 10.1136/heartjnl-2024-325150.
    PubMed     Abstract available
    
    
    
41. TREWAREE S, Shantsila A, Lip GYH
    Pulse pressure and aortic valve peak velocity as new predictors of heart failure in patients post-myocardial infarction.
    Heart. 2025 Feb 6:heartjnl-2024-325513. doi: 10.1136/heartjnl-2024-325513.
    PubMed    
    
    
    
42. OKADA T, Kagiyama N, Kaneko T, Amano M, et al
    Echocardiographic cardiac damage classification and clinical outcomes in atrial functional mitral regurgitation.
    Heart. 2025 Feb 6:heartjnl-2024-325240. doi: 10.1136/heartjnl-2024-325240.
    PubMed     Abstract available
    
    
    
43. WU Y, Zhao J, Chen C, Huang J, et al
    Pulse pressure and aortic valve peak velocity and incident heart failure after myocardial infarction: a cohort study.
    Heart. 2025 Feb 6:heartjnl-2024-324517. doi: 10.1136/heartjnl-2024-324517.
    PubMed     Abstract available
    
    
    January 2025
44. CHRISTENSEN EB, Vissing CR, Silajdzija E, Mills HL, et al
    Long-term incidence of implantable cardioverter-defibrillator therapy in patients with hypertrophic cardiomyopathy: analysis of appropriate and inappropriate interventions.
    Heart. 2025 Jan 19:heartjnl-2024-325020. doi: 10.1136/heartjnl-2024-325020.
    PubMed     Abstract available
    
    
    
45. CRAIG N, Dweck MR
    Sociodemographic treatment trends for aortic stenosis since the adoption of transcatheter aortic valve intervention.
    Heart. 2025 Jan 16:heartjnl-2024-325328. doi: 10.1136/heartjnl-2024-325328.
    PubMed    
    
    
    
46. DONAL E, Gegout L, Bourg C
    Reassessing the role of tricuspid valve surgery in the modern era.
    Heart. 2025 Jan 16:heartjnl-2024-325476. doi: 10.1136/heartjnl-2024-325476.
    PubMed    
    
    
    December 2024
47. LIU R, Fu Z, Yan Y, Xie M, et al
    New wearable cardiac acoustic monitoring technology for evaluation of subclinical leaflet thrombosis after transcatheter aortic valve replacement.
    Heart. 2024 Dec 25:heartjnl-2024-324698. doi: 10.1136/heartjnl-2024-324698.
    PubMed     Abstract available
    
    
    
48. DOEDENS A, Skarp S, Holmstrom L, Pakanen L, et al
    Genetic variants associated with cardiac hypertrophy-related sudden cardiac death and cardiovascular outcomes in a Finnish population.
    Heart. 2024;111:55-61.
    PubMed     Abstract available
    
    
    
49. PLAYFORD D, Stewart S, Harris SA, Scalia G, et al
    Mortality associated with moderate and severe mitral regurgitation in 608 570 men and women undergoing echocardiography.
    Heart. 2024 Dec 20:heartjnl-2024-324790. doi: 10.1136/heartjnl-2024-324790.
    PubMed     Abstract available
    
    
    
50. HADJI-TURDEGHAL K, Petersen JK, Graversen PL, Butt JH, et al
    Bacteraemia after transcatheter aortic valve implantation: a nationwide cohort study.
    Heart. 2024 Dec 20:heartjnl-2024-324803. doi: 10.1136/heartjnl-2024-324803.
    PubMed     Abstract available
    
    
    
51. GWAK SY, Kim K, Lee HJ, Cho I, et al
    Outcomes of tricuspid valve surgery in patients with significant tricuspid regurgitation and low to intermediate risk.
    Heart. 2024 Dec 17:heartjnl-2024-324891. doi: 10.1136/heartjnl-2024-324891.
    PubMed     Abstract available
    
    
    
52. YONES E, Gunn J, Iqbal J, Morris PD, et al
    Functional assessment of coronary artery disease in patients with severe aortic stenosis: a review.
    Heart. 2024 Dec 12:heartjnl-2024-324802. doi: 10.1136/heartjnl-2024-324802.
    PubMed     Abstract available
    
    
    
53. DIGREGORIO H, Mansoorshahi S, Carlisle SG, Tovar Pensa C, et al
    Contribution of rare chromosome 22q11.2 copy number variants to non-syndromic bicuspid aortic valve.
    Heart. 2024 Dec 10:heartjnl-2024-324669. doi: 10.1136/heartjnl-2024-324669.
    PubMed     Abstract available
    
    
    November 2024
54. SINGH A, Chalmers F, Aslam S, Bolton T, et al
    Surgical and transcatheter aortic valve interventions for aortic stenosis in England: sociodemographic variations in treatment trends and outcome over 20 years.
    Heart. 2024 Nov 27:heartjnl-2024-324918. doi: 10.1136/heartjnl-2024-324918.
    PubMed     Abstract available
    
    
    
55. DONAL E, Rouleau L
    Optimising management of moderate secondary mitral regurgitation: insights into pharmacological and interventional approaches.
    Heart. 2024 Nov 7:heartjnl-2024-325097. doi: 10.1136/heartjnl-2024-325097.
    PubMed    
    
    
    
56. BJORN R, Strom JB, Lloyd G, Bhattacharyya S, et al
    Asymptomatic severe degenerative mitral regurgitation.
    Heart. 2024 Nov 7:heartjnl-2024-324739. doi: 10.1136/heartjnl-2024-324739.
    PubMed     Abstract available
    
    
    October 2024
57. SARRAZYN C, Fortuni F, Laenens D, Chua AP, et al
    Clinical and echocardiographic parameters associated with outcomes in patients with moderate secondary mitral regurgitation.
    Heart. 2024 Oct 4:heartjnl-2024-324526. doi: 10.1136/heartjnl-2024-324526.
    PubMed     Abstract available
    
    
    September 2024
58. LAI FY, Gibbison B, O'Cathain A, Akowuah E, et al
    Inequalities in access to and outcomes of cardiac surgery in England: retrospective analysis of Hospital Episode Statistics (2010-2019).
    Heart. 2024 Sep 3:heartjnl-2024-324292. doi: 10.1136/heartjnl-2024-324292.
    PubMed     Abstract available
    
    
    August 2024
59. GALLI E, Le Ven F, Coisne A, Sportouch C, et al
    Randomised study for the Optimal Treatment of symptomatic patients with low-gradient severe Aortic valve Stenosis and preserved left ventricular ejection fraction (ROTAS trial).
    Heart. 2024 Aug 28:heartjnl-2024-324224. doi: 10.1136/heartjnl-2024-324224.
    PubMed     Abstract available
    
    
    
60. JAHANGIRI M, Prendergast B
    Management of bicuspid aortic valve disease in the transcatheter aortic valve implantation era.
    Heart. 2024 Aug 7:heartjnl-2024-324054. doi: 10.1136/heartjnl-2024-324054.
    PubMed     Abstract available
    
    
    June 2024
61. RHEE TM, Kim HK
    Integrating machine learning approach to identify sleep-disordered breathing in hypertrophic cardiomyopathy.
    Heart. 2024;110:931-932.
    PubMed    
    
    
    
62. AKITA K, Kageyama S, Suzuki S, Ohno K, et al
    Machine learning-based detection of sleep-disordered breathing in hypertrophic cardiomyopathy.
    Heart. 2024;110:954-962.
    PubMed     Abstract available
    
    
    
63. KLADOU E, Kochiadakis G, Hamilos M
    Unexpected finding on imaging: an aortic valve mass.
    Heart. 2024;110:939-970.
    PubMed    
    
    
    April 2024
64. KUMAR M, Pettinato A, Ladha F, Earp JE, et al
    Sarcopenia and aortic valve disease.
    Heart. 2024 Apr 22:heartjnl-2024-324029. doi: 10.1136/heartjnl-2024-324029.
    PubMed     Abstract available
    
    
    March 2024
65. BIEROWSKI MJ, Warner ED, Edirisuriya CD
    Mitral valve dysfunction in a woman with newly diagnosed acute promyelocytic leukemia.
    Heart. 2024;110:507-540.
    PubMed    
    
    
    February 2024
66. UBBEN T, Frerker C, Fujita B, Rosenkranz S, et al
    Association of pulmonary hypertension with the outcome in patients undergoing edge-to-edge mitral valve repair.
    Heart. 2024 Feb 22:heartjnl-2023-323473. doi: 10.1136/heartjnl-2023-323473.
    PubMed     Abstract available
    
    
    
67. TA S, Li J, Hsi DH, Hu R, et al
    Percutaneous intramyocardial septal radiofrequency ablation after 5-year follow-up.
    Heart. 2024 Feb 22:heartjnl-2023-323606. doi: 10.1136/heartjnl-2023-323606.
    PubMed     Abstract available
    
    
    January 2024
68. WACHTELL K
    Understanding the driving mechanisms of bioprosthetic valve degeneration.
    Heart. 2024;110:223-224.
    PubMed    
    
    
    
69. GUAL-CAPLLONCH F, Pericas P
    Correspondence on 'Echocardiographic estimation of pulmonary pressure in patients with severe tricuspid regurgitation' by Lemarchand et al.
    Heart. 2024 Jan 18:heartjnl-2023-323697. doi: 10.1136/heartjnl-2023-323697.
    PubMed    
    
    
    December 2023
70. PATEL KP, McKenna M, Thornton GD, Vandermolen S, et al
    Predictors of outcome in patients with moderate mixed aortic valve disease.
    Heart. 2023 Dec 26:heartjnl-2023-323321. doi: 10.1136/heartjnl-2023-323321.
    PubMed     Abstract available
    
    
    
71. DELWARDE C, Toquet C, Boureau AS, Le Ruz R, et al
    Filamin A heart valve disease as a genetic cause of inherited bicuspid and tricuspid aortic valve disease.
    Heart. 2023 Dec 26:heartjnl-2023-323491. doi: 10.1136/heartjnl-2023-323491.
    PubMed     Abstract available
    
    
    
72. PAVON AG, Guglielmo M
    Carcinoid heart disease: another step into the knowledge of a rare disease.
    Heart. 2023;110:79-80.
    PubMed    
    
    
    
73. MONDAL S, Kumar SS, Kesavan V
    Case of presyncope with mitral regurgitation.
    Heart. 2023;110:18-74.
    PubMed    
    
    
    
74. SATURI G, De Frutos F, Sguazzotti M, Gonzalez-Lopez E, et al
    Predictors and outcomes of pacemaker implantation in patients with cardiac amyloidosis.
    Heart. 2023;110:40-48.
    PubMed     Abstract available
    
    
    
75. JANDER N, Minners J
    Towards a gender-specific and morphology-specific assessment of aortic valve stenosis severity.
    Heart. 2023 Dec 12:heartjnl-2023-323499. doi: 10.1136/heartjnl-2023-323499.
    PubMed    
    
    
    
76. SCARSINI R, Portolan L, Della Mora F, Fabroni M, et al
    Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation.
    Heart. 2023 Dec 1:heartjnl-2023-323461. doi: 10.1136/heartjnl-2023-323461.
    PubMed     Abstract available
    
    
    November 2023
77. HAZEBROEK MR, Verdonschot JAJ
    One step closer to the new frontiers of healthcare for cardiomyopathy patients.
    Heart. 2023;109:1808-1810.
    PubMed    
    
    
    
78. ANDERSON RH, Spicer DE, Sanchez-Quintana D, Macias Y, et al
    Relationship between the aortic root and the atrioventricular conduction axis.
    Heart. 2023;109:1811-1818.
    PubMed     Abstract available
    
    
    
79. ANDERSON RH, Westaby J, Sheppard MN, Cook AC, et al
    Mitral annular disjunction: a ubiquitous finding with or without mitral valvar prolapse.
    Heart. 2023 Nov 24:heartjnl-2023-323501. doi: 10.1136/heartjnl-2023-323501.
    PubMed    
    
    
    
80. HEUTS S, Gabrio A, Veenstra L, Maesen B, et al
    Stroke reduction by cerebral embolic protection devices in transcatheter aortic valve implantation: a systematic review and Bayesian meta-analysis.
    Heart. 2023 Nov 23:heartjnl-2023-323359. doi: 10.1136/heartjnl-2023-323359.
    PubMed     Abstract available
    
    
    
81. LAWIN D, Stellbrink C, Stellbrink E, Buck B, et al
    Alcohol septal ablation in patients aged 75 years or older with hypertrophic obstructive cardiomyopathy.
    Heart. 2023;109:1778-1784.
    PubMed     Abstract available
    
    
    
82. BAROUTIDOU A, Arvanitaki A, Farmakis IT, Patsiou V, et al
    Transcatheter closure of atrial septal defect in the elderly: a systematic review and meta-analysis.
    Heart. 2023;109:1741-1750.
    PubMed     Abstract available
    
    
    
83. KRAWCZYK-OZOG A, Batko J, Zdzierak B, Dziewierz A, et al
    Morphology of the mural and commissural atrioventricular junction of the mitral valve.
    Heart. 2023 Nov 7:heartjnl-2023-322965. doi: 10.1136/heartjnl-2023-322965.
    PubMed     Abstract available
    
    
    
84. TOMASELLI M, Badano LP, Muraru D
    Right atrial function, a mostly ignored but very valuable parameter in patients with secondary tricuspid regurgitation.
    Heart. 2023 Nov 6:heartjnl-2023-323426. doi: 10.1136/heartjnl-2023-323426.
    PubMed    
    
    
    
85. BOTEZATU SB, Yu X, Meah MN, Williams MC, et al
    Aortic valve perivascular adipose tissue computed tomography attenuation in patients with aortic stenosis.
    Heart. 2023 Nov 2:heartjnl-2023-323217. doi: 10.1136/heartjnl-2023-323217.
    PubMed     Abstract available
    
    
    October 2023
86. GALLOO X, Fortuni F, Meucci MC, Butcher SC, et al
    Association of right atrial strain and long-term outcome in severe secondary tricuspid regurgitation.
    Heart. 2023 Oct 30:heartjnl-2023-323084. doi: 10.1136/heartjnl-2023-323084.
    PubMed     Abstract available
    
    
    
87. YE Z, Clavel MA, Foley TA, Pibarot P, et al
    Computed tomography calcium scoring in aortic stenosis: bicuspid versus tricuspid morphology.
    Heart. 2023 Oct 30:heartjnl-2023-323281. doi: 10.1136/heartjnl-2023-323281.
    PubMed     Abstract available
    
    
    
88. CHA MJ, Lee SA, Cho MS, Nam GB, et al
    Reduction of moderate to severe tricuspid regurgitation after catheter ablation for atrial fibrillation.
    Heart. 2023 Oct 25:heartjnl-2023-323244. doi: 10.1136/heartjnl-2023-323244.
    PubMed     Abstract available
    
    
    
89. LEMARCHAND L, Auffret V, Le Breton H, Bedossa M, et al
    Echocardiographic estimation of pulmonary pressure in patients with severe tricuspid regurgitation.
    Heart. 2023 Oct 12:heartjnl-2023-322893. doi: 10.1136/heartjnl-2023-322893.
    PubMed     Abstract available
    
    
    
90. OTTO CM, Bartkowiak J, Hahn RT
    Right atrial pressure, not Doppler jet velocity, is the problem in estimating pulmonary pressure when tricuspid regurgitation is severe.
    Heart. 2023 Oct 12:heartjnl-2023-323230. doi: 10.1136/heartjnl-2023-323230.
    PubMed    
    
    
    
91. VEERARAGHAVAN S, Kidambi BR
    Sudden-onset breathlessness in a middle-aged man.
    Heart. 2023;109:1601-1650.
    PubMed    
    
    
    
92. DEMAL TJ, Conradi L
    Management of valve dysfunction in patients with mitral annular calcification.
    Heart. 2023;109:1639-1646.
    PubMed    
    
    
    September 2023
93. OTTO CM
    Heartbeat: a trend over the past 20 years towards decreased aortic stenosis mortality in patients aged 80 years or older.
    Heart. 2023;109:1419-1421.
    PubMed    
    
    
    
94. MICHELENA HI, Anand V, Enriquez-Sarano M, Pellikka PA, et al
    Correspondence on 'Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes' by Ratwatte et al.
    Heart. 2023 Sep 1:heartjnl-2023-323347. doi: 10.1136/heartjnl-2023-323347.
    PubMed    
    
    
    
95. RATWATTE S, Celermajer DS
    Response to: Correspondence on 'Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes' by Michelena et al.
    Heart. 2023 Sep 1:heartjnl-2023-323348. doi: 10.1136/heartjnl-2023-323348.
    PubMed    
    
    
    August 2023
96. FARINA JM, Chao CJ, Pereyra M, Roarke M, et al
    Role of lipoprotein(a) concentrations in bioprosthetic aortic valve degeneration.
    Heart. 2023 Aug 29:heartjnl-2023-322987. doi: 10.1136/heartjnl-2023-322987.
    PubMed     Abstract available
    
    
    
97. BARNES C, Sharma H, Gamble J, Dawkins S, et al
    Management of secondary mitral regurgitation: from drugs to devices.
    Heart. 2023 Aug 22:heartjnl-2022-322001. doi: 10.1136/heartjnl-2022-322001.
    PubMed     Abstract available
    
    
    
98. JANG MH, Ahn JM, Kang DY, Kim KW, et al
    Impact of leaflet thrombosis on valve haemodynamic status after transcatheter aortic valve replacement.
    Heart. 2023 Aug 16:heartjnl-2023-322946. doi: 10.1136/heartjnl-2023-322946.
    PubMed     Abstract available
    
    
    
99. XU Z, Gong C, Chen Y
    Patient in their 40s with unexplained myocardial hypertrophy.
    Heart. 2023;109:1280-1340.
    PubMed    
    
    
    
100. OTTO CM
     Heartbeat: elevated pulmonary pressures in adults with aortic valve disease.
     Heart. 2023;109:1263-1265.
     PubMed    
     
     
     
101. KUSUNOSE K, Ikemiyagi H
     Prognostic implications of pulmonary vascular resistance in transcatheter aortic valve implantation.
     Heart. 2023 Aug 8:heartjnl-2023-323094. doi: 10.1136/heartjnl-2023-323094.
     PubMed    
     
     
     July 2023
102. LIEBENBERG J, Doubell A, Steyn J, Herbst P, et al
     Exploring the mechanisms responsible for reduced systolic function in high-gradient aortic stenosis.
     Heart. 2023 Jul 24:heartjnl-2023-322727. doi: 10.1136/heartjnl-2023-322727.
     PubMed     Abstract available
     
     
     
103. MASSERA D, Bartz TM, Biggs ML, Sotoodehnia N, et al
     Traditional and novel risk factors for incident aortic stenosis in community-dwelling older adults.
     Heart. 2023 Jul 18:heartjnl-2023-322709. doi: 10.1136/heartjnl-2023-322709.
     PubMed     Abstract available
     
     
     
104. MARTINSSON A, Torngren C, Nielsen SJ, Pan E, et al
     Renin-angiotensin system inhibition after surgical aortic valve replacement for aortic stenosis.
     Heart. 2023 Jul 17:heartjnl-2023-322922. doi: 10.1136/heartjnl-2023-322922.
     PubMed     Abstract available
     
     
     
105. LUMISH HS, Liang LW, Hasegawa K, Maurer MS, et al
     Prediction of worsening heart failure in hypertrophic cardiomyopathy using plasma proteomics.
     Heart. 2023 Jul 14:heartjnl-2023-322644. doi: 10.1136/heartjnl-2023-322644.
     PubMed     Abstract available
     
     
     
106. AFOKE J, Camacho E, Bagameri G
     Recurrent ventricular arrhythmia after aortic root replacement and mitral valve repair.
     Heart. 2023;109:1145-1192.
     PubMed    
     
     
     
107. FARRANT J, Dodd S, Vaughan C, Reid A, et al
     Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy.
     Heart. 2023;109:1175-1182.
     PubMed     Abstract available
     
     
     
108. CARDAIOLI F, Nai Fovino L, Fabris T, Masiero G, et al
     Updated definition of pulmonary hypertension and outcome after transcatheter aortic valve implantation.
     Heart. 2023 Jul 6:heartjnl-2023-322881. doi: 10.1136/heartjnl-2023-322881.
     PubMed     Abstract available
     
     
     
109. HOHMANN C, Pfister R, Frerker C, Beckmann A, et al
     Direct oral anticoagulants versus vitamin K antagonist after transcatheter aortic valve implantation.
     Heart. 2023 Jul 5:heartjnl-2023-322548. doi: 10.1136/heartjnl-2023-322548.
     PubMed     Abstract available
     
     
     June 2023
110. NGUYEN DD, Arnold SV
     Impact of frailty on disease-specific health status in cardiovascular disease.
     Heart. 2023;109:977-983.
     PubMed     Abstract available
     
     
     
111. COURTNEY WA, Schultz CJ, Hillis GS
     Aortic valve calcification and outcomes in severe aortic stenosis.
     Heart. 2023 Jun 8:heartjnl-2023-322771. doi: 10.1136/heartjnl-2023-322771.
     PubMed    
     
     
     
112. CHOI Y, Ahn JM, Yang DH, Koo HJ, et al
     Clinical outcomes after aortic valve replacement with severe stenosis of trileaflet aortic valve and low valve calcium score.
     Heart. 2023 Jun 8:heartjnl-2023-322435. doi: 10.1136/heartjnl-2023-322435.
     PubMed     Abstract available
     
     
     
113. SAN ROMAN JA, Ybarra-Falcon C, Garcia-Gomez M, Ramos N, et al
     Recurrence of syncope after valve replacement in severe aortic stenosis.
     Heart. 2023 Jun 7:heartjnl-2023-322859. doi: 10.1136/heartjnl-2023-322859.
     PubMed     Abstract available
     
     
     May 2023
114. PISLARU SV, Nkomo VT
     Subannular repair for secondary mitral regurgitation: a step towards peaceful conversations.
     Heart. 2023 May 31:heartjnl-2023-322609. doi: 10.1136/heartjnl-2023-322609.
     PubMed    
     
     
     
115. NIENABER CA, Yuan X, Nienaber SA
     Aortic stenosis may not be fatal anymore in wealthy societies: but what about the rest of the world?
     Heart. 2023 May 26:heartjnl-2023-322737. doi: 10.1136/heartjnl-2023-322737.
     PubMed    
     
     
     
116. SEVILLA T, Rojas G, Gonzalez-Bartol E, Candela J, et al
     Magnetic resonance analysis of ventricular volumes in bicuspid and trileaflet aortic regurgitation.
     Heart. 2023 May 25:heartjnl-2023-322519. doi: 10.1136/heartjnl-2023-322519.
     PubMed     Abstract available
     
     
     
117. ANGUITA-GAMEZ M, Giraldo MA, Nombela-Franco L, Eixeres Esteve A, et al
     Validation of the TRI-SCORE in patients undergoing surgery for isolated tricuspid regurgitation.
     Heart. 2023 May 22:heartjnl-2022-322067. doi: 10.1136/heartjnl-2022-322067.
     PubMed     Abstract available
     
     
     
118. HIBINO M, Pandey AK, Hibino H, Verma R, et al
     Mortality trends of aortic stenosis in high-income countries from 2000 to 2020.
     Heart. 2023 May 19:heartjnl-2023-322397. doi: 10.1136/heartjnl-2023-322397.
     PubMed     Abstract available
     
     
     
119. OTTO CM
     Heartbeat: Choice of aortic valve intervention in younger adults.
     Heart. 2023;109:807-809.
     PubMed    
     
     
     
120. SHAH BN
     National Institute for Health and Care Excellence (NICE) guidance on heart valve disease.
     Heart. 2023;109:817-822.
     PubMed     Abstract available
     
     
     
121. VAN HOOF L, Lamberigts M, Noe D, El-Hamamsy I, et al
     Matched comparison between external aortic root support and valve-sparing root replacement.
     Heart. 2023;109:832-838.
     PubMed     Abstract available
     
     
     
122. NUNES MCP, Barbosa JAA, Mocumbi A
     Refining morphological echocardiographic criteria to improve early detection of rheumatic heart disease.
     Heart. 2023 May 12:heartjnl-2022-322325. doi: 10.1136/heartjnl-2022-322325.
     PubMed    
     
     
     
123. OH JK, Shen M, Guzzetti E, Tastet L, et al
     Effect of race on pressure recovery adjustment for prevention of aortic stenosis grading discordance.
     Heart. 2023 May 5:heartjnl-2023-322586. doi: 10.1136/heartjnl-2023-322586.
     PubMed     Abstract available
     
     
     
124. LEEDY D, Elison DM, Farias F, Cheng R, et al
     Transcatheter aortic valve intervention in patients with cancer.
     Heart. 2023 May 5:heartjnl-2022-321396. doi: 10.1136/heartjnl-2022-321396.
     PubMed     Abstract available
     
     
     
125. GALIAN-GAY L, Pijuan-Domenech A, Cantalapiedra-Romero J, Serrano B, et al
     Pregnancy-related aortic complications in women with bicuspid aortic valve.
     Heart. 2023 May 5:heartjnl-2022-322328. doi: 10.1136/heartjnl-2022-322328.
     PubMed     Abstract available
     
     
     
126. SAN ROMAN JA
     Correspondence on "Outcomes in patients with moderate and asymptomatic severe aortic stenosis followed up in heart valve clinics" by Paolisso et al.
     Heart. 2023 May 3:heartjnl-2023-322844. doi: 10.1136/heartjnl-2023-322844.
     PubMed    
     
     
     
127. VAN CAMP G
     Response to: Correspondence on "Outcomes in patients with moderate and asymptomatic severe aortic stenosis followed up in heart valve clinics" by Jose Alberto San Roman.
     Heart. 2023 May 3:heartjnl-2023-322845. doi: 10.1136/heartjnl-2023-322845.
     PubMed    
     
     
     April 2023
128. HUNTER LD, Doubell AF, Pecoraro AJK, Monaghan M, et al
     Morpho-mechanistic screening criteria for the echocardiographic detection of rheumatic heart disease.
     Heart. 2023 Apr 28:heartjnl-2022-322192. doi: 10.1136/heartjnl-2022-322192.
     PubMed     Abstract available
     
     
     
129. OTTO CM
     Heartbeat: sudden cardiac death risk in patients with hypertrophic cardiomyopathy.
     Heart. 2023;109:725-727.
     PubMed    
     
     
     
130. RUBIS P
     Low-normal systolic function and hypertrophic cardiomyopathy.
     Heart. 2023;109:732-733.
     PubMed    
     
     
     
131. CHOI YJ, Kim HK, Hwang IC, Park CS, et al
     Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction.
     Heart. 2023;109:771-778.
     PubMed     Abstract available
     
     
     
132. CRAMARIUC D, Urheim S
     Pulmonary hypertension in significant aortic valve disease: a dive into real-world data.
     Heart. 2023 Apr 24:heartjnl-2023-322495. doi: 10.1136/heartjnl-2023-322495.
     PubMed    
     
     
     
133. RATWATTE S, Playford D, Stewart S, Strange G, et al
     Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes.
     Heart. 2023 Apr 3:heartjnl-2022-322187. doi: 10.1136/heartjnl-2022-322187.
     PubMed     Abstract available
     
     
     
134. RATWATTE S, Stewart S, Strange G, Playford D, et al
     Prevalence of pulmonary hypertension in aortic stenosis and its influence on outcomes.
     Heart. 2023 Apr 3:heartjnl-2022-322184. doi: 10.1136/heartjnl-2022-322184.
     PubMed     Abstract available
     
     
     March 2023
135. PAUSCH J, Harmel E, Reichenspurner H, Kempfert J, et al
     Subannular repair in secondary mitral regurgitation with restricted leaflet motion during systole.
     Heart. 2023 Mar 27:heartjnl-2022-322239. doi: 10.1136/heartjnl-2022-322239.
     PubMed     Abstract available
     
     
     
136. OTTO CM
     Heartbeat: heart valve clinics improve outcomes in patients with aortic valve stenosis.
     Heart. 2023;109:573-575.
     PubMed    
     
     
     
137. BISWAS A, Shukla A, Kothari SS
     Typical effort angina in a tall adult.
     Heart. 2023;109:605-650.
     PubMed    
     
     
     
138. GARTSHTEYN Y, Bhave N, Joseph MS, Askanase A, et al
     Inflammatory and thrombotic valvulopathies in autoimmune disease.
     Heart. 2023;109:583-588.
     PubMed     Abstract available
     
     
     
139. MARON MS, Rowin E, Spirito P, Maron BJ, et al
     Differing strategies for sudden death prevention in hypertrophic cardiomyopathy.
     Heart. 2023;109:589-594.
     PubMed     Abstract available
     
     
     
140. VELDERS BJJ, Vriesendorp MD, De Lind Van Wijngaarden RAF, Rao V, et al
     Perioperative care differences of surgical aortic valve replacement between North America and Europe.
     Heart. 2023 Mar 24:heartjnl-2023-322350. doi: 10.1136/heartjnl-2023-322350.
     PubMed     Abstract available
     
     
     
141. GEERS J, Bing R
     Computed tomographic imaging of patients with native and prosthetic aortic valve stenosis.
     Heart. 2023 Mar 22:heartjnl-2022-321660. doi: 10.1136/heartjnl-2022-321660.
     PubMed    
     
     
     
142. BEYER SE, Secemsky EA, Khabbaz K, Carroll BJ, et al
     Elective ascending aortic aneurysm repair outcomes in a nationwide US cohort.
     Heart. 2023 Mar 16:heartjnl-2022-322033. doi: 10.1136/heartjnl-2022-322033.
     PubMed     Abstract available
     
     
     
143. ALI Z, Flynn AW
     Severe aortic stenosis and the need for the right treatment, in the right place, at the right time.
     Heart. 2023 Mar 13:heartjnl-2022-322195. doi: 10.1136/heartjnl-2022-322195.
     PubMed    
     
     
     
144. OTTO CM
     Heartbeat: clinical practice patterns for valve intervention in adults with aortic stenosis.
     Heart. 2023;109:495-497.
     PubMed    
     
     
     February 2023
145. KRIEGER EV, Burke CR, McCabe JM
     Sometimes mechanical, never routine: aortic valve replacement in young adults.
     Heart. 2023 Feb 27:heartjnl-2022-322150. doi: 10.1136/heartjnl-2022-322150.
     PubMed    
     
     
     
146. STOICA S, Beard C, Takkenberg JJM, Mokhles MM, et al
     Formal consensus study on surgery to replace the aortic valve in adults aged 18-60 years.
     Heart. 2023 Feb 27:heartjnl-2022-321740. doi: 10.1136/heartjnl-2022-321740.
     PubMed     Abstract available
     
     
     
147. DREYFUS J, Bohbot Y, Coisne A, Lavie-Badie Y, et al
     Predictive value of the TRI-SCORE for in-hospital mortality after redo isolated tricuspid valve surgery.
     Heart. 2023 Feb 24:heartjnl-2022-322167. doi: 10.1136/heartjnl-2022-322167.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge.